0001683168-24-000709.txt : 20240206
0001683168-24-000709.hdr.sgml : 20240206
20240206102823
ACCESSION NUMBER: 0001683168-24-000709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240206
DATE AS OF CHANGE: 20240206
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mahery Amy
CENTRAL INDEX KEY: 0002008489
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39126
FILM NUMBER: 24598778
MAIL ADDRESS:
STREET 1: C/O CNS PHARMACEUTICALS, INC.
STREET 2: 2100 WEST LOOP SOUTH, SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001729427
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 822318545
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
BUSINESS PHONE: 1-800-946-9185
MAIL ADDRESS:
STREET 1: 2100 WEST LOOP SOUTH
STREET 2: SUITE 900
CITY: HOUSTON
STATE: TX
ZIP: 77027
4
1
ownership.xml
X0508
4
2024-02-01
0
0001729427
CNS Pharmaceuticals, Inc.
CNSP
0002008489
Mahery Amy
C/O CNS PHARMACEUTICALS, INC.
100 WEST LOOP SOUTH, SUITE 900
HOUSTON
TX
77027
1
0
0
0
0
Option to purchase common stock
0.2525
2024-02-01
4
A
0
12420
A
2034-02-01
Common Stock
12420
12420
D
The options set forth in this table vest in 36 equal monthly installments succeeding the issuance date, or February 1, 2024, subject to the grantee's continued service on the Company's Board of Directors on each vesting date.
The options were issued in connection with the reporting person's Board of Director services to the Company.
/s/ Christopher Downs, Attorney-in-Fact
2024-02-05